Integration of personalised ultrasensitive ctDNA monitoring of patients with metastatic breast cancer to reduce imaging requirements.
Mouhanna P, Ståhlberg A, Andersson D, Albu-Kareem A, Elinder E, Eriksson O, Kavanagh A, Kovács A, Larsson KF, Linderholm B, Uminska M, Österlund T, Howell SJ, Ekholm M.
Mouhanna P, et al. Among authors: kavanagh a.
Int J Cancer. 2024 Dec 18. doi: 10.1002/ijc.35292. Online ahead of print.
Int J Cancer. 2024.
PMID: 39692755